Endometriosis Treatment Market Projected to Reach $3.1 Billion by 2034: Advancements in Surgery and Fertility Therapies Fuel Growth PharmiWeb.com
Endometriosis drug research, long underfunded, confronts familiar problems in women’s health BioPharma Dive
Ovary Removal May Raise Women's Alzheimer's Risk Newsmax
Virginia tennis’ Danielle Collins and Emma Navarro representing Team USA at the Olympics MSN
To evaluate the cost-effectiveness of long-acting progestogens (LAP), including levonorgestrel-releasing intrauterine system (LNG-IUS) and depot-medroxyprogesterone acetate (DMPA), compared with the combined oral contraceptives pill (COCP) in preventing recurrence of endometriosis-related …
Endometrial cancer (EC), endometriosis (ENDO), and obesity (OBY) are interconnected conditions in women that may share underlying genetic pathways. This study aimed to identify shared genetic pathways and differential gene …
Endometriosis is a chronic inflammatory disease for which there is currently no accurate screening test to identify or predict the probability of the disease in individuals. This can often lead …
To determine the changes in procedural utilization for symptomatic uterine fibroids and adenomyosis over the past decade.
Endometriosis and its associated gynecological diseases such as female infertility and primary ovarian failure (POF), impose a long-term disease burden on women. This study aims to explore the causal relationships …
Subtle uterine lesions are abnormal intracavitary conditions that, while not causing significant anatomical changes, can adversely impact fertility. Identifying these "subtle" lesions is challenging due to arbitrary interpretation, varied management …